Customers First Focus

Your success is Certara’s guiding principle. Trusted by more than 2,000 active customers across 62 countries, we are members of your team.

We design and implement drug development strategies using quantitative science and an integrated approach to:

Get to proof of concept faster
Optimize trial design
Reduce trial size or avoid certain trials altogether
Expedite regulatory submissions
Expand patient access to medicines

Uncompromising Quality

The high quality of our work is the result of dedication, collaboration, and deep expertise.

By choosing to partner with Certara, you tap into the expertise and insights of more than 1,100 leading drug development, regulatory science, and market access solutions’ experts who are committed to finding the right answers and increasing the probability of your success.

We navigate complexity through flawless execution and stewardship with our top scientists and experts in pursuit of your goals.

Our History

In 2008, Tripos International and Pharsight Corporation came together to form Certara. Since then, we have achieved incredible growth through fourteen acquisitions and the adoption of model-informed drug development by industry and regulatory agencies.

Today, we are the global leader in biosimulation. Our quantitative science approach and unique portfolio of software and services that span the entire lifecycle accelerate medicines to patients, in concert with you.

We will continue expanding boundaries to make the drug development research and process more efficient and medicines safer and better for patients.

Certara Downloads

Phoenix NLME - Version 8.3 - Modern Population PK/PD Modeling Tool Brochure

Phoenix WinNonlin SoftwareBrochure

Phoenix - Version 8.3 - Pharmacokinetic and Pharmacodynamic (PK/PD) Platform Brochure